Literature DB >> 2966068

Plasma concentrations of atrial natriuretic peptide in patients with artificial and transplanted hearts.

G Deray1, G Maistre, P Cacoub, A Carayon, P Leger, J Rottembourg, M Anouar, P Sassano, C Cabrol.   

Abstract

Plasma atrial natriuretic peptide (ANP) concentrations were measured by radioimmunoassay 1 to 12 days after operation in six patients with artificial hearts. The mean levels were significantly higher in artificial heart recipients (58.2 pg.ml-1) than in controls (12.6 pg.ml-1). The mechanism underlying the raised values is not clear, although it is suggested that elevated atrial pressure may have been the stimulus for higher ANP release. In 3 patients plasma ANP concentrations were also measured 1 to 5 days after orthotopic transplantation. In all of them ANP concentrations had increased by 20 to 74% despite lower right atrial pressure. An increase in atrial tissue mass may have contributed to the raised plasma ANP after orthotopic transplantation. It also suggests that the functioning sympathetic nervous system is not a necessary condition for ANP release.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2966068     DOI: 10.1007/bf01061425

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  10 in total

Review 1.  The atrial natriuretic factor.

Authors:  J Genest
Journal:  Br Heart J       Date:  1986-10

2.  Atrial endocrine function in humans with artificial hearts.

Authors:  T R Schwab; B S Edwards; W C DeVries; R S Zimmerman; J C Burnett
Journal:  N Engl J Med       Date:  1986-11-27       Impact factor: 91.245

3.  Raised concentrations of plasma atrial natriuretic peptides in cardiac transplant recipients.

Authors:  D R Singer; M G Buckley; G A Macgregor; A Khaghani; N R Banner; M H Yacoub
Journal:  Br Med J (Clin Res Ed)       Date:  1986-11-29

4.  The role of left atrial receptors in th diuretic response to left atrial distension.

Authors:  J R Ledsome; R J Linden
Journal:  J Physiol       Date:  1968-09       Impact factor: 5.182

5.  Atrial natriuretic peptide in plasma of volume-overloaded children with chronic renal failure.

Authors:  W Rascher; T Tulassay; R E Lang
Journal:  Lancet       Date:  1985-08-10       Impact factor: 79.321

6.  Plasma atrial natriuretic peptide in cardiac disease and during infusion in healthy volunteers.

Authors:  I Tikkanen; F Fyhrquist; K Metsärinne; R Leidenius
Journal:  Lancet       Date:  1985-07-13       Impact factor: 79.321

7.  Temporary use of the Jarvik-7 total artificial heart before transplantation.

Authors:  B P Griffith; R L Hardesty; R L Kormos; A Trento; H S Borovetz; M E Thompson; H T Bahnson
Journal:  N Engl J Med       Date:  1987-01-15       Impact factor: 91.245

8.  Specific membrane receptors for atrial natriuretic factor in renal and vascular tissues.

Authors:  M A Napier; R L Vandlen; G Albers-Schönberg; R F Nutt; S Brady; T Lyle; R Winquist; E P Faison; L A Heinel; E H Blaine
Journal:  Proc Natl Acad Sci U S A       Date:  1984-10       Impact factor: 11.205

9.  Atrial pressure and secretion of atrial natriuretic factor into the human central circulation.

Authors:  R J Rodeheffer; I Tanaka; T Imada; A S Hollister; D Robertson; T Inagami
Journal:  J Am Coll Cardiol       Date:  1986-07       Impact factor: 24.094

10.  Atrial natriuretic peptide and atrial pressure in patients with congestive heart failure.

Authors:  A E Raine; P Erne; E Bürgisser; F B Müller; P Bolli; F Burkart; F R Bühler
Journal:  N Engl J Med       Date:  1986-08-28       Impact factor: 91.245

  10 in total
  6 in total

1.  Beta-adrenoceptor blockade potentiates exercise-induced release of atrial natriuretic peptide.

Authors:  G Deray; I Berlin; G Maistre; F Martinez; S Legrand; A Carayon; A Prost; A Puech; F Masson; J C Legrand
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

2.  Beta-adrenoceptor blockade potentiates acute exercise-induced release of atrial natriuretic peptide by increasing atrial diameter in normotensive healthy subjects.

Authors:  I Berlin; P Lechat; G Deray; C Landault; G Maistre; V Chermat; R Brouard; C Ressayre; A J Puech
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

3.  Low molecular weight hydroxyethyl starch 6% compared to albumin 4% during intentional hemodilution.

Authors:  J F Baron; D De Kegel; A C Prost; O Mundler; M Arthaud; G Basset; G Maistre; F Masson; A Carayon; C Landault
Journal:  Intensive Care Med       Date:  1991       Impact factor: 17.440

4.  Atrial natriuretic peptide level and intracardiac pressure in cardiac transplant recipients.

Authors:  G Deray; G Maistre; M Desruenne; J Eurin; C Barthelemy; F Masson; A Baumelou; P Leger; C Cabrol; J C Legrand
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

5.  Atrial natriuretic factor in patients with acromegaly.

Authors:  G Deray; P Chanson; G Maistre; A Warnet; J Eurin; C Barthelemy; F Masson; F Martinez; J Lubetzki; J C Legrand
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

6.  Atrial natriuretic peptide responses during anaesthesia in patients with refractory cardiomyopathies.

Authors:  S N Glisson; G E Gutzke; R Pifarre; T L Rao
Journal:  Can J Anaesth       Date:  1991-07       Impact factor: 5.063

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.